Issue 1/2011
Content (38 Articles)
PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer
Marleen Kok, Wilbert Zwart, Caroline Holm, Renske Fles, Michael Hauptmann, Laura J. Van’t Veer, Lodewyk F. A. Wessels, Jacques Neefjes, Olle Stål, Sabine C. Linn, Göran Landberg, Rob Michalides
Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells
S. Petersson, E. Shubbar, M. Yhr, A. Kovacs, C. Enerbäck
Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells
Laura B. Carpin, Lissett R. Bickford, Germaine Agollah, Tse-Kuan Yu, Rachel Schiff, Yi Li, Rebekah A. Drezek
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines
Lynnette Fernández-Cuesta, Suresh Anaganti, Pierre Hainaut, Magali Olivier
Biological and clinical implications of nicastrin expression in invasive breast cancer
Aleksandra Filipović, Julian Hendrik Gronau, Andrew R. Green, Jayson Wang, Sabari Vallath, Dongmin Shao, Sabeena Rasul, Ian O. Ellis, Ernesto Yagüe, Justin Sturge, R. Charles Coombes
Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells
Hyun Chang, Hei-Cheul Jeung, Je Jun Jung, Tae Soo Kim, Sun Young Rha, Hyun Cheol Chung
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
Sylvain Ladoire, Laurent Arnould, Grégoire Mignot, Bruno Coudert, Cédric Rébé, Fanny Chalmin, Julie Vincent, Mélanie Bruchard, Bruno Chauffert, François Martin, Pierre Fumoleau, François Ghiringhelli
Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins
Ching-Shyang Chen, Chia-Hwa Lee, Chang-Da Hsieh, Chi-Tang Ho, Min-Hsiung Pan, Ching-Shui Huang, Shih-Hsin Tu, Ying-Jan Wang, Li-Ching Chen, Yu-Jia Chang, Po-Li Wei, Yi-Yuan Yang, Chih-Hsiung Wu, Yuan-Soon Ho
Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2
Kai-xin Zhang, Connie Kim, Elaine Chow, Irvin S. Y. Chen, William Jia, Paul S. Rennie
Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01)
Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hwa Jung Kim, Keun-Suk Lee, Jung-Sil Ro, Yun-Hee Park, Jin-Suk Ahn, Young-Hyk Im, Seock-Ah Im, Moon-Hee Lee, Si-Young Kim
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer
Jiyoung Rhee, Sae-Won Han, Yongjun Cha, Hye Seon Ham, Hwang-phill Kim, Do-Youn Oh, Seock-Ah Im, Jong-Wan Park, Jungsil Ro, Keun Seok Lee, In Hae Park, Young-Hyuck Im, Yung-Jue Bang, Tae-You Kim
Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study
Nicholas Robert, Lea Krekow, Chris Stokoe, Alicia Clawson, Jose Iglesias, Joyce O’Shaughnessy
Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision
Vincent Lavoué, Claire Marie Roger, Mathieu Poilblanc, Nicolas Proust, Camille Monghal-Verge, Christine Sagan, Patrick Tas, Habiba Mesbah, Philippe Porée, Catherine Gay, Gilles Body, Jean Levêque
Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patients
Mathias Warm, Ronald Kates, Friedrich Overkamp, Anke Thomas, Nadia Harbeck
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, Mary Wilkinson, Yvonne Ottaviano, Gina G. Chung, Robert Warren, Jennifer Eng-Wong, Philip Cohen, Karen L. Smith, Karen Creswell, Antonella Novielli, Rebecca Slack
Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
Gunter von Minckwitz, Michael Untch, Eveline Nüesch, Sibylle Loibl, Manfred Kaufmann, Sherko Kümmel, Peter A. Fasching, Wolfgang Eiermann, Jens-Uwe Blohmer, Serban Dan Costa, Keyur Mehta, Jörn Hilfrich, Christian Jackisch, Bernd Gerber, Andreas du Bois, Jens Huober, Claus Hanusch, Gottfried Konecny, Werner Fett, Elmar Stickeler, Nadia Harbeck, Volkmar Müller, Peter Jüni
RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects
Haiming Sun, Jing Bai, Feng Chen, Yan Jin, Yang Yu, Lianhong Jin, Songbin Fu
Preventable breast cancer is postmenopausal
Kari Hemminki, Asta Försti, Jan Sundquist, Seyed Mohsen Mousavi
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families
Larissa A. Korde, Christine M. Mueller, Jennifer T. Loud, Jeffery P. Struewing, Kathy Nichols, Mark H. Greene, Phuong L. Mai
Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects
Haiming Sun, Jing Bai, Feng Chen, Yan Jin, Yang Yu, Songbin Fu
Associations between mammographic density and serum and dietary cholesterol
Ame-Lia Tamburrini, Christy G. Woolcott, Norman F. Boyd, Martin J. Yaffe, Tim Terry, Yutaka Yasui, Charlotte A. Jones, Scott B. Patten, Kerry S. Courneya, Christine M. Friedenreich
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
Rebecca L. Sedjo, Scott Devine
No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects
Yanlei Ma, Jianjun Yang, Zhihua Liu, Peng Zhang, Zhe Yang, Yu Wang, Huanlong Qin
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk
Genevieve M. Monsees, Peter Kraft, Stephen J. Chanock, David J. Hunter, Jiali Han
The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects
Yiyi Sun, Zhihe Zang, Xiaohong Xu, Zhonglin Zhang, Ling Zhong, Wang Zan, Yan Zhao, Lin Sun
Centrosome-related genes, genetic variation, and risk of breast cancer
J. E. Olson, X. Wang, V. S. Pankratz, Z. S. Fredericksen, C. M. Vachon, R. A. Vierkant, J. R. Cerhan, F. J. Couch
No evidence of MMTV-like env sequences in specimens from the Australian Breast Cancer Family Study
Daniel J. Park, Melissa C. Southey, Graham G. Giles, John L. Hopper
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects
Yanlei Ma, Jianjun Yang, Peng Zhang, Zhihua Liu, Zhe Yang, Huanlong Qin
Aromatase immunoreactivity is increased in mammographically dense regions of the breast
Celine M. Vachon, Hironobu Sasano, Karthik Ghosh, Kathleen R. Brandt, David A. Watson, Carol Reynolds, Wilma L. Lingle, Paul E. Goss, Rong Li, Sarah E. Aiyar, Christopher G. Scott, V. Shane Pankratz, Richard J. Santen, James N. Ingle
Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects
Su Lu, Zhanwei Wang, Dan Cui, Hong Liu, Xishan Hao
No evidence for an association of human papillomavirus and breast carcinoma
Raimundo Gerônimo Silva Jr., Benedito Borges da Silva
A recombination-based method to characterize human BRCA1 missense variants
Lucia Guidugli, Chiara Rugani, Grazia Lombardi, Paolo Aretini, Alvaro Galli, Maria Adelaide Caligo
Regional and seasonal influence in patient’s toxicity to adjuvant chemotherapy for early breast cancer
Juan de la Haba-Rodríguez, Álvaro Rodríguez-Lescure, Amparo Ruiz, Emilio Alba, Lourdes Calvo, Eva Carrasco, Maria Jose Escudero, Miguel Martín
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
Alastair M. Thompson, Andrea Johnson, Philip Quinlan, Grantland Hillman, Marcel Fontecha, Susan E. Bray, Colin A. Purdie, Lee B. Jordan, Roberta Ferraldeschi, Ayshe Latif, Kirsten D. Hadfield, Robert B. Clarke, Linda Ashcroft, D. Gareth Evans, Anthony Howell, Michele Nikoloff, Jeffrey Lawrence, William G. Newman
Pharmacological interventions for fertility preservation during chemotherapy
Zeev Blumenfeld
Lack of association between two SNPs (rs1800896 and rs1800872) in IL-10 gene promoter and breast cancer in Caucasians
Yan-Feng Zou, Fang Wang, Xiao-Liang Feng
Presence of MMTV-like env gene sequences in human breast cancer
Beatriz G.-T. Pogo, Stella M. Melana, Heberth Moran, James F. Holland
Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk
Pei-Hua Lu, Chen Li, Hong-Yi Zhou, Tong Wang, Chun-Qiang Chu, Wei Shen, Guo-Qing Tao